Daiichi Sankyo, GlaxoSmithKline deal

Daiichi Sankyo and GlaxoSmithKline launched their 50/50 vaccines JV, Japan Vaccine Co. Ltd. (Tokyo, Japan), for the late-stage development and commercialization of the partners' respective vaccines in...